Analysis Sarepta Stock Tanks As DMD Gene Therapy Fails Confirmatory Study, Risks Market WithdrawalNovember 2, 2023 Lemon_tm Sarepta Therapeutics (NASDAQ:SRPT) shares are in free-fall today after its gene therapy drug ELEVIDYS, granted accelerate approval to treat…
